A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder

This double-blind, randomized study evaluated the efficacy and safety of trazodone OAD (once-a-day) in comparison with venlafaxine XR (extended-release) in 324 patients (166 trazodone and 158 venlafaxine) with major depressive disorder (MDD). The primary efficacy endpoint was the mean change from ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Fagiolini, Andrea, Albert, Umberto, Ferrando, Laura, Herman, Erik, Muntean, Cosmina, Pálová, Eva, Cattaneo, Agnese, Comandini, Alessandro, Di Dato, Giorgio, Di Loreto, Giorgio, Olivieri, Luisa, Salvatori, Enrica, Tongiani, Serena, Kasper, Siegfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099841/
https://www.ncbi.nlm.nih.gov/pubmed/31972628
http://dx.doi.org/10.1097/YIC.0000000000000304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099841/
https://www.ncbi.nlm.nih.gov/pubmed/31972628
http://dx.doi.org/10.1097/YIC.0000000000000304

Ejemplares similares